RED BANK, N.J. -- Donna Hatcher has been named business development manager of acute care for Ansell Professional Healthcare. She will be responsible for coordinating market-related activities associated with Ansell's professional product lines, with an emphasis on planning and supporting the marketing and sales program.
Hatcher comes to Ansell from Boston Scientific, where she served as group product manager of endourology marketing. Prior to joining Boston Scientific, she was product director of global product management, cardiology, with Cordis, a Johnson & Johnson Company.
"With 10 years of progressive product marketing, communications and market research experience, Hatcher brings to Ansell an impressive background in international medical device products, managed care and medical education," said Bill Reed, senior vice president and regional director, Ansell Americas.
Hatcher is a graduate of Ohio University, where she earned a master's degree in business administration. She also holds bachelor's and master's degrees in fine arts and human nutrition from Ohio University.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.